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ABSTRACT
Clinical trials are observations or experiments performed in clinical research. It is customary for researchers to publish 
their interim findings during the course of the trial. However, publishing the final results and outcomes is imperative. The 
CONSORT statement was developed to aid the randomized control clinical trial’s authors to standardize the reporting of 
the trial’s design, analysis, and interpretation of the results. Readers need to understand all the trial outcomes irrespective 
of whether they are beneficial or harmful as these impact future research. Well-reported clinical trials are a must as these 
provide the basis for systemic reviews, meta-analyses, and eventual clinical guidelines.
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Introduction
A clinical trial is a prospective biomedical or behavioral 
research study that involves the participation of humans. 
The trial is designed to answer questions about particular 
interventions such as new medications, vaccines, dietary 
supplements, and medical devices, amongst others. The 
most common type of clinical trial is a randomized control 
trial (RCT). RCTs are the gold standard research design 
to evaluate and efficiently translate research data into 
clinical practice.[1] In such a clinical trial, the participants 
are randomly allocated to either the “intervention group,” 
which is the group receiving the treatment under study, 
or else allocated to the “control group.” The latter group 
receives standard treatment or else a placebo treatment. It 
is customary for the process to be blinded (single or double) 
apart from being randomized.
A clinical trial is set to progress through four phases; however, 
not all trials reach the end phase due to various reasons such 
as the development of an unexpected complication(s) or 
mortality, amongst others.
It is important that clinical trials get registered to national 
clinical trial registers and obtain an authentic trial 
number. Trials can be registered to more than one register 
simultaneously. Such a registering process ensures 
transparency of the trial design while the outcomes are 
authenticated and patented to the research body.
Publishing Clinical Trials
It is common practice that during the ongoing trial phases, 
the researchers start to publish interim findings. In order 
to aid such reporting, the CONSORT statement has been 
developed for the reporting of RCTs. The CONSORT 
statement is made up of a 25‑checklist guideline and a 
flowchart that aids the author to present the trial’s protocol, 
results, and outcomes in a scientific and ethical manner.[2,3] 
In fact, a number of journals are considering the CONSORT 
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statement as a requisite for submitting RCT articles for 
publication.
When publishing interim findings, researchers should ensure 
that such publications are limited to the protocol of specified 
analyses that enabled the identification of statistically stable 
outcome(s). It is further suggested that when publishing such 
findings, the article title should include the word “interim.” 
Meanwhile within the article, justification for publishing 
interim results should be provided.[4]
Regretfully, a percentage of the clinical trials (more than 
a third) only publish interim findings and fail to report the 
final results and outcomes. Furthermore, it is not uncommon 
that the final outcome(s) and conclusion(s) are altered from 
the initial setout plan.[5] It is essential for the trial’s final results 
to be published in scientific journals since these provide the 
evidence to whether the trial obtained a beneficial or harmful 
or no outcome(s).[4] In addition, the readers will not be able to 
adequately critically appraise the clinical trial unless the end 
results are published. Furthermore, it is an obligation of the 
trial researchers to publish the clinical trial full results. The 
trial would have exposed humans to potential risks during 
its course and failing to publish the results would be ethically 
unacceptable as well as violating the Helsinki Declaration.[6,7] 
Unfortunately, it was reported that only 60% of the RCTs are 
fully published in scientific journals.[8] Regretfully, trials that 
obtain a positive outcome are more likely to be published 
than those obtaining a negative outcome.[8] However, such 
editorial practice is perilous since negative outcomes do not 
imply a failed trial. Rather, reporting of negative outcomes 
would enable other researchers to improve future protocol(s) 
or avoid pertaining the same research protocol.
Clinical trial data provide the basis of systemic reviews 
and meta‑analyses, leading to the development of clinical 
guidelines.[6] Hence, publishing of the clinical trial results 
throughout the different trial phases and eventually reporting 
the final outcome(s) would enhance the effectiveness of 
systemic reviews, meta‑analyses, and clinical guidelines.
Visibility of Clinical Trial Publications
When a clinical trial is published, it is recommended that 
the manuscript title includes the words “clinical trial” 
in order to ensure correct indexing of the manuscript in 
electronic databases. Correct indexing of the published 
manuscript is of utmost importance to ensure identification 
of the manuscript as describing a clinical trial. Furthermore, 
correct indexing also enhances the visibility of a researcher’s 
work and increases the citation potential of the published 
manuscript. Citation of published manuscripts is imperative 
for the enhancement of the researcher’s research metrics 
and for increasing the prestigious acknowledgment of the 
researcher and his/her work within the scientific community.[9]
Conclusion
Clinical trials should have their interim and final outcomes 
published in scientific journals. Journal editors should permit the 
publication of the trial’s outcome(s) irrelevant of its beneficial or 
harmful nature. Clinical trial publications provide the basis for 
systemic reviews, meta‑analyses, and eventual clinical guidelines.
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